SWK
67
-4
CMCSA
48
-2
DAL
79
-4
PM
66
4
MSI
73
3
ZTS
47
-9
WU
34
-2
ADBE
61
11
UA
57
-8
ADSK
68
-2
HCP
62
-8
DUK
64
7
VRTX
55
2
OI
38
-5
MHK
50
-5
LB
60
4
TAP
63
2
SO
62
3
FTI
84
2
EXPD
48
-5
SWK
67
-4
CMCSA
48
-2
DAL
79
-4
PM
66
4
MSI
73
3
ZTS
47
-9
WU
34
-2
ADBE
61
11
UA
57
-8
ADSK
68
-2
HCP
62
-8
DUK
64
7
VRTX
55
2
OI
38
-5
MHK
50
-5
LB
60
4
TAP
63
2
SO
62
3
FTI
84
2
EXPD
48
-5
Financhill
Back

Amicus Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
34

FOLD
Amicus Therapeutics

Last Price:
9.90
Seasonality Move:
7.75%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.24
Seasonality Move:
14.88%
Sell
34
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $9.87. The Score for FOLD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $9.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 38.25 Sell
Chaikin Money Flow: 826536 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.87 - 11.53) Sell
Bollinger Bands (100): (10.16 - 11.54) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.65 Buy
20-day SMA: 10.48 Sell
50-day SMA: 10.75 Sell
200-day SMA: 10.94 Sell
8-day EMA: 9.82 Buy
20-day EMA: 10.25 Sell
50-day EMA: 10.64 Sell
200-day EMA: 10.98 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):